Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN79529838
ISRCTN79529838
Completed
Not Applicable

Evaluating the response to suspected disease outbreaks using a short message service (SMS) model: a cluster randomized controlled trial

agasaki University (Japan)0 sites153 target enrollmentJune 7, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions14 priority diseases that require immediate reporting: adverse events following immunization, anthrax, cholera, Guinea worm, measles, neonatal tetanus, plague, Rift Valley fever, severe acute respiratory infections, viral hemorrhagic fever, yellow fever, and other (any public health event of national and international concerns).Infections and Infestations

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
14 priority diseases that require immediate reporting: adverse events following immunization, anthrax, cholera, Guinea worm, measles, neonatal tetanus, plague, Rift Valley fever, severe acute respiratory infections, viral hemorrhagic fever, yellow fever, and other (any public health event of national and international concerns).
Sponsor
agasaki University (Japan)
Enrollment
153
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
agasaki University (Japan)

Eligibility Criteria

Inclusion Criteria

  • •1\. Health facilities that are listed on the Kenya Master Facility List (MFL)
  • •2\. Health facilities that offer curative services
  • •3\. Health facilities that are operational
  • •4\. Interviews will be conducted with health workers and disease surveillance coordinators who are literate and can comprehend English

Exclusion Criteria

  • •1\. Health facilities that are not listed on MFL
  • •2\. Health facilities that do not offer curative services
  • •3\. Health facility in\-charges or a representative who cannot send SMS during training
  • •4\. Health facilities that do not have mobile phone network coverage in the area

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapyhematological malignancies oral mucositis associated with cancer therapy
JPRN-UMIN000016948niversity of Hyogo20
Recruiting
Not Applicable
Examine the patient's response and symptom improvement using the intervention under the Integrated Approach to Symptom Management Model for the patients who has lymphedemalymphedema associated with cancer therapy
JPRN-UMIN000014469niversity of Hyogo20
Completed
Not Applicable
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drugskin toxicity associated with molecularly targeted drug
JPRN-UMIN000016947niversity of Hyogo20
Completed
Not Applicable
Examination of diagnosis and treatment evaluation of leg and foot fatigue fractures by X-ray grating interferometer (Talbot-Lau interferomete)
JPRN-UMIN000028903Department of Orthopeadic Surgery, Tohoku University Hospital40
Recruiting
Phase 2
Pathologic response, side-effects, and overall survival in cervical cancer under treatment with neo-adjuvant chemotherapy and surgerylocally advanced cervical cancer.Malignant neoplasm of cervix uteri
IRCT2017090236033N1Vice-chancellery for Research of Mashhad University of Medicla Sciences30